September 24, 2017 5:43 AM ET

Biotechnology

Company Overview of Juno Therapeutics, Inc.

Executive Profile

Robert T. Nelsen

Co-Founder and Director, Juno Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 21 Board Members in 21 organization across 33 different industries.

See Board Relationships
55$354,154

Background

Mr. Robert T. Nelsen, also known as Bob, is a Co-Founder, Partner and Managing Director of ARCH Venture Partners, L.P., ARCH Venture Fund V, L.P., Arch Venture Fund VIII, L.P. and ARCH Venture Fund VI, L.P. Mr. Nelsen joined ARCH at its founding and played a significant role in the early sourcing, financing and development of more than thirty companies, including 15 which have reached valuations exceeding $1 billion. He focuses on alternative energy, biotechnology, pharmaceuticals, ...

Corporate Headquarters

400 Dexter Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

Director
Director
Director
Director
Director
Director
Trustee
Director
Director
Chairman
Director
Director
Director
Co-Founder and Director
2000-Present
Independent Director
2007-Present
Director
2011-Present
Director
2011-Present
Director
2013-Present
Co-Founder and Director
2015-Present
Director

Education

MBA
The University of Chicago
BS
University of Puget Sound

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$12,000
Unexercisable Options$12,000
Total Number of Options$24,000

Total Compensation

Total Calculated Compensation$354,154
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
--
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juno Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.